Is USANA Health Sciences (USNA) a Great Value Stock Right Now?
Werte in diesem Artikel
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use tried-and-true metrics and fundamental analysis to find companies that they believe are undervalued at their current share price levels.Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today.One company value investors might notice is USANA Health Sciences (USNA). USNA is currently sporting a Zacks Rank of #1 (Strong Buy), as well as an A grade for Value.Investors should also note that USNA holds a PEG ratio of 1.12. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. USNA's PEG compares to its industry's average PEG of 2.01. USNA's PEG has been as high as 1.55 and as low as 1.02, with a median of 1.31, all within the past year.Another valuation metric that we should highlight is USNA's P/B ratio of 1.31. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. This stock's P/B looks attractive against its industry's average P/B of 1.33. USNA's P/B has been as high as 2.22 and as low as 1.19, with a median of 1.69, over the past year.These are only a few of the key metrics included in USANA Health Sciences's strong Value grade, but they help show that the stock is likely undervalued right now. When factoring in the strength of its earnings outlook, USNA looks like an impressive value stock at the moment.Zacks Naming Top 10 Stocks for 2025Want to be tipped off early to our 10 top picks for the entirety of 2025?History suggests their performance could be sensational.From 2012 (when our Director of Research Sheraz Mian assumed responsibility for the portfolio) through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&P 500’s +475.6%. Now Sheraz is combing through 4,400 companies to handpick the best 10 tickers to buy and hold in 2025. Don’t miss your chance to get in on these stocks when they’re released on January 2.Be First to New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report USANA Health Sciences, Inc. (USNA): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf USANA Health Sciences
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf USANA Health Sciences
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu USANA Health Sciences Inc.
Analysen zu USANA Health Sciences Inc.
Datum | Rating | Analyst | |
---|---|---|---|
16.04.2019 | USANA Health Sciences Buy | Tigress Financial | |
24.10.2018 | USANA Health Sciences Buy | Pivotal Research Group | |
23.04.2018 | USANA Health Sciences Hold | Pivotal Research Group | |
07.02.2018 | USANA Health Sciences Buy | Pivotal Research Group | |
25.10.2017 | USANA Health Sciences Buy | Pivotal Research Group |
Datum | Rating | Analyst | |
---|---|---|---|
16.04.2019 | USANA Health Sciences Buy | Tigress Financial | |
24.10.2018 | USANA Health Sciences Buy | Pivotal Research Group | |
07.02.2018 | USANA Health Sciences Buy | Pivotal Research Group | |
25.10.2017 | USANA Health Sciences Buy | Pivotal Research Group | |
26.07.2017 | USANA Health Sciences Buy | Pivotal Research Group |
Datum | Rating | Analyst | |
---|---|---|---|
23.04.2018 | USANA Health Sciences Hold | Pivotal Research Group | |
01.05.2017 | USANA Health Sciences Hold | Pivotal Research Group | |
06.08.2015 | USANA Health Sciences Neutral | D.A. Davidson & Co. | |
23.04.2015 | USANA Health Sciences Hold | Canaccord Adams | |
30.10.2014 | USANA Health Sciences Hold | Canaccord Adams |
Datum | Rating | Analyst | |
---|---|---|---|
29.04.2010 | USANA "underperform" | Wedbush Morgan Securities Inc. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für USANA Health Sciences Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen